Latest Innovations
The Latest Life Science Innovations Changing Patients Lives
Click the social share buttons below to keep your network up to date on the latest life science innovations changing patients lives.
Sign Up - Newsletter
Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry
The Latest on Life Science Innovations
The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of December 19, 2024, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are
-
Amgen’s Blincyto has demonstrated a 96% survival rate for those living with standard-risk B-cell acute lymphoblastic leukemia remaining disease-free for three years when combined with chemotherapy.
-
Pfizer’s Ibrance has demonstrated a significant benefit in treating a type of metastatic breast cancer, reducing the risk of progression or death by 26% when combined with standard therapies, offering a new option in a competitive market.
-
San Diego’s life sciences sector which provide about $56 billion in economic output, is set to expand with over 3.2 million square feet of new lab space in 2025, adding to the life science biotech boom in California.